WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	107,861	113,802	92,943	128,366	123,616	138,481
Market Cap Growth	31.77%	22.44%	-27.59%	3.84%	-10.73%	-26.91%
Enterprise Value	107,145	114,670	101,308	130,632	113,324	119,353
Last Close Price	8170.00	8620.00	7040.00	9730.00	9270.64	10388.65
PE Ratio	21.73	22.91	19.43	16.13	49.86	32.48
PS Ratio	1.01	1.07	0.91	1.60	1.91	2.41
PB Ratio	1.10	1.16	1.00	1.42	1.49	1.71
P/TBV Ratio	1.15	1.22	1.05	1.46	1.54	1.75
P/FCF Ratio	19.67	20.76	12.79	-	-	102.25
P/OCF Ratio	15.91	16.78	9.65	-	22.98	17.27
EV/Sales Ratio	1.01	1.08	0.99	1.63	1.75	2.08
EV/EBITDA Ratio	10.99	11.77	10.73	12.15	16.60	18.69
EV/EBIT Ratio	18.92	20.25	17.90	16.52	23.23	24.43
EV/FCF Ratio	19.54	20.91	13.94	-	-	88.13
Debt / Equity Ratio	0.19	0.19	0.26	0.22	0.26	0.29
Debt / EBITDA Ratio	1.92	1.92	2.55	1.86	3.14	3.62
Debt / FCF Ratio	3.42	3.42	3.31	-	-	17.06
Net Debt / Equity Ratio	-0.01	-0.01	0.06	0.10	-0.06	-0.24
Net Debt / EBITDA Ratio	-0.07	-0.07	0.55	0.82	-0.75	-3.03
Net Debt / FCF Ratio	-0.13	-0.13	0.71	-0.73	0.51	-14.30
Asset Turnover	0.79	0.79	0.77	0.64	0.54	0.51
Inventory Turnover	2.14	2.14	2.31	2.52	3.07	2.98
Quick Ratio	1.37	1.37	1.21	1.20	1.74	2.55
Current Ratio	2.06	2.06	1.80	1.88	2.33	3.19
Return on Equity (ROE)	5.20%	5.20%	5.22%	9.19%	3.02%	5.41%
Return on Assets (ROA)	2.61%	2.61%	2.67%	3.95%	2.56%	2.71%
Return on Invested Capital (ROIC)	5.77%	5.79%	5.34%	7.78%	4.17%	6.84%
Return on Capital Employed (ROCE)	5.50%	5.50%	5.60%	7.90%	5.20%	5.10%
Earnings Yield	4.61%	4.37%	5.15%	6.20%	2.01%	3.08%
FCF Yield	5.08%	4.82%	7.82%	-9.38%	-8.05%	0.98%
Payout Ratio	-	-	27.57%	-	25.53%	9.90%
Buyback Yield / Dilution	0.05%	0.05%	-0.21%	-0.03%	0.10%	-59.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.